Haleon plc (NYSE:HLN) Shares Sold by Lake Street Advisors Group LLC

Lake Street Advisors Group LLC decreased its position in shares of Haleon plc (NYSE:HLN) by 21.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,545 shares of the company’s stock after selling 4,850 shares during the period. Lake Street Advisors Group LLC’s holdings in Haleon were worth $167,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its stake in Haleon by 29.8% during the 4th quarter. Bank of New York Mellon Corp now owns 2,071,017 shares of the company’s stock worth $19,758,000 after acquiring an additional 475,934 shares in the last quarter. Wrapmanager Inc. acquired a new position in Haleon during the 4th quarter worth about $112,000. Addison Advisors LLC lifted its stake in Haleon by 28.7% during the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock worth $47,000 after acquiring an additional 1,106 shares in the last quarter. Holistic Financial Partners lifted its stake in Haleon by 14.2% during the 4th quarter. Holistic Financial Partners now owns 12,207 shares of the company’s stock worth $116,000 after acquiring an additional 1,518 shares in the last quarter. Finally, Callan Capital LLC lifted its stake in Haleon by 30.0% during the 4th quarter. Callan Capital LLC now owns 36,266 shares of the company’s stock worth $346,000 after acquiring an additional 8,359 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Price Performance

HLN stock opened at $10.18 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market capitalization of $46.06 billion, a P/E ratio of 29.93, a P/E/G ratio of 2.82 and a beta of 0.28. The business’s 50-day moving average is $9.59 and its two-hundred day moving average is $9.83. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80.

Haleon (NYSE:HLN) last issued its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Analysts anticipate that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HLN shares. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Haleon has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.